Taiwan FDA registration b9dfc875ba058b1e91ac75274be1b3a4
Minxiang anti-blood group reagent
TW: 敏翔抗A血型試劑
Taiwan·Taiwan Fu Pharmaceutical Co., Ltd·Registered Apr 19, 2004 – Apr 19, 2009CancelledRegistration details
- Analysis ID
- b9dfc875ba058b1e91ac75274be1b3a4
- Customs Code
- DHY00500110501
Company information
- Manufacturer
- Taiwan Fu Pharmaceutical Co., Ltd
- Manufacturer Country
- Taiwan, Province of China
- Authorized Representative
- Qi Xiang Biotechnology Co., Ltd
Product details
- Product Type (Level 1)
- B Hematology, pathology, and genetics
- Import Information
- Domestic
Dates and status
- Registration Date
- Apr 19, 2004
- Expiry Date
- Apr 19, 2009
- Cancellation Date
- Nov 07, 2012
Cancellation information
- Status
- Logged out
- Reason
- 許可證已逾有效期
About this record
Access comprehensive regulatory information for Minxiang anti-blood group reagent in Taiwan's medical device market through Pure Global AI's free database. is registered under number b9dfc875ba058b1e91ac75274be1b3a4 and manufactured by Taiwan Fu Pharmaceutical Co., Ltd. The authorized representative in Taiwan is Qi Xiang Biotechnology Co., Ltd.
This page provides complete technical specifications, regulatory compliance details. Pure Global AI offers free access to 89,000+ Taiwan medical device registrations, helping global MedTech companies navigate Taiwan FDA regulations, identify competitors, and discover partnership opportunities efficiently.
Free DatabasePowered by Pure Global AI89,000+ Devices